Anthropic’s pending Nasdaq IPO, now slated for mid-November marketing after recent delays, anchors trader sentiment around ticker speculation, with $ANTH holding the highest implied probability at 35% due to its direct alignment with the company name. Strong revenue expansion—reaching $11.5 billion in the latest reported quarter and annualized run rates exceeding $65 billion—supports elevated valuations near $2 trillion, yet substantial operating losses and $518 billion in projected infrastructure outlays introduce uncertainty that keeps probabilities dispersed. $ANT follows at 20% as a concise alternative, while lower-priced options like $CLDE reflect limited consensus on creative variants ahead of any official disclosure.